Challenges to glycemic measurement in the perioperative and critically ill patient: A review

Journal of Diabetes Science and Technology

Volumn 3, Issue 6, 2009, Pages 1270-1281

  Pitkin, Andrew D ^a   Rice, Mark J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Glucometer; Glucose measurement; Intense insulin therapy; Intraoperative; Laboratory; Perioperative; Point of care device

Indexed keywords

BLOOD; BLOOD GLUCOSE MONITORING; CRITICAL ILLNESS; EQUIPMENT; EQUIPMENT DESIGN; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HOSPITAL INFORMATION SYSTEM; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSTRUMENTATION; INTENSIVE CARE; METABOLISM; PERIOPERATIVE PERIOD; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW; SURGERY;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CRITICAL CARE; CRITICAL ILLNESS; DIAGNOSTIC EQUIPMENT; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; HUMANS; HYPOGLYCEMIA; INPATIENTS; PERIOPERATIVE CARE; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SURGICAL PROCEDURES, OPERATIVE;

EID: 77249140803     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300606     Document Type: Conference Paper

References (70)

1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
2. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
3. Marik PE, Varon J. Intensive insulin therapy in the ICU: is it now time to jump off the bandwagon? Resuscitation. 2007;74(1):191-93. (Pubitemid 46891675)
4. Ramos M, Khalpey Z, Lipsitz S, Steinberg J, Panizales MT, Zinner M, Rogers SO. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg. 2008;248(4):585-91.
5. Vilar-Compte D, Alvarez de Iturbe I, Martin-Onraet A, Perez-Amador M, Sanchez-Hernandez C, Volkow P. Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomy. Am J Infect Control. 2008;36(3):192-8. (Pubitemid 351419199)
6. Park C, Hsu C, Neelakanta G, Nourmand H, Braunfeld M, Wray C, Steadman RH, Hu KQ, Cheng RT, Xia VW. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation. 2009;87(7):1031-6.
7. McGirt MJ, Woodworth GF, Brooke BS, Coon AL, Jain S, Buck D, Huang J, Clatterbuck RE, Tamargo RJ, Perler BA. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery. 2006;58(6):1066-73.
8. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2002;49(5):531-7. (Pubitemid 35333999)
9. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, Schrader LM, Rizza RA, McMahon MM. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80(7):862-6. (Pubitemid 40911459)
10. Furnary AP, Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Semin Thorac Cardiovasc Surg. 2006;18(4):302-8. (Pubitemid 46464509)
11. Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, Bridges CR, Haan CK, Svedjeholm R, Taegtmeyer H, Shemin RJ; Society of Thoracic Surgeons Blood Glucose Guideline Task Force. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663-9.
12. Andreelli F, Jacquier D, Troy S. Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care. 2006;9(2):124-30. (Pubitemid 44090036)
13. Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg. In press 2009.
14. Shuldiner AR, McLenithan JC. Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again. J Clin Invest. 2004;114(10):1414-7. (Pubitemid 40385572)
15. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114(2):147-52. (Pubitemid 39071617)
16. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care. 2008;31 Suppl 1:S12-54.
17. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13 Suppl 1:1-68.
18. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296-327.
19. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Can Med Assoc J. 2009;180(8):821-7.
20. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association Consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353-69.
21. Burrin JM, Alberti KG. What is blood glucose: can it be measured? Diabet Med. 1990;7(3):199-206. (Pubitemid 20104132)
22. D'Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Kulpmann WR, Larsson L, Lewenstam A, Maas AH, Mager G, Naskalski JW, Okorodudu AO; IFCC-SD-WG-SEPOCT. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med. 2006;44(12):1486-90.
23. Neely RD, Kiwanuka JB, Hadden DR. Influence of sample type on the interpretation of the oral glucose tolerance test for gestational diabetes mellitus. Diabet Med. 1991;8(2):129-34.
24. D'Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Kulpmann WR, Larsson L, Lewenstam A, Maas AH, Mager G, Naskalski JW, Okorodudu AO; International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem. 2005;51(9):1573-6. (Pubitemid 41233089)
25. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: World Health Organization; 2006.
26. Stahl M, Brandslund I, Jorgensen LG, Hyltoft Petersen P, Borch-Johnsen K, de Fine Olivarius N. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest. 2002;62(2):159-66. (Pubitemid 34407553)
27. Carstensen B, Lindstrom J, Sundvall J, Borch-Johnsen K, Tuomilehto J. Measurement of blood glucose: comparison between different types of specimens. Ann Clin Biochem. 2008;45(Pt 2):140-8. (Pubitemid 351724584)
28. Karon BS, Gandhi GY, Nuttall GA, Bryant SC, Schaff HV, McMahon MM, Santrach PJ. Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol. 2007;127(6):919-26.
29. Maser RE, Butler MA, DeCherney GS. Use of arterial blood with bedside glucose reflectance meters in an intensive care unit: are they accurate? Crit Care Med. 1994;22(4):595-9. (Pubitemid 24121559)
30. Petersen JR, Graves DF, Tacker DH, Okorodudu AO, Mohammad AA, Cardenas VJ Jr. Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on a tight glycemic protocol. Clin Chim Acta. 2008;396(1-2):10-3.
31. Slater-MacLean L, Cembrowski G, Chin D, Shalapay C, Binette T, Hegadoren K, Newburn-Cook C. Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther. 2008;10(3):169-77. (Pubitemid 351677597)
32. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778-85. (Pubitemid 41816412)
33. Atkin SH, Dasmahapatra A, Jaker MA, Chorost MI, Reddy S. Fingerstick glucose determination in shock. Ann Intern Med. 1991;114(12):1020-4.
34. Sylvain HF, Pokorny ME, English SM, Benson NH, Whitley TW, Ferenczy CJ, Harrison JG. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care. 1995;4(1):44-8.
35. Critchell CD, Savarese V, Callahan A, Aboud C, Jabbour S, Marik P. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med. 2007;33(12):2079-84. (Pubitemid 350164561)
36. Desachy A, Vuagnat AC, Ghazali AD, Baudin OT, Longuet OH, Calvat SN, Gissot V. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc. 2008;83(4):400-5. (Pubitemid 351536465)
37. Dacombe CM, Dalton RG, Goldie DJ, Osborne JP. Effect of packed cell volume on blood glucose estimations. Arch Dis Child. 1981;56(10):789-91. (Pubitemid 11031688)
38. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403-9. (Pubitemid 46198356)
39. Louie RF, Tang Z, Sutton, DV, Lee JH, Kost GJ. Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med. 2000;124(2):257-66. (Pubitemid 30090612)
40. Dahlberg M, Whitelaw A. Evaluation of HemoCue Blood Glucose Analyzer for the instant diagnosis of hypoglycaemia in newborns. Scand J Clin Lab Invest. 1997;57(8):719-24. (Pubitemid 28020556)
41. Ho HT, Yeung WK, Young BW. Evaluation of "point of care" devices in the measurement of low blood glucose in neonatal practice. Arch Dis Child Fetal Neonatal Ed. 2004;89(4):F356-9. (Pubitemid 38869682)
42. Rosenthal M, Ugele B, Lipowsky G, Kuster H. The Accutrend sensor glucose analyzer may not be adequate in bedside testing for neonatal hypoglycemia. Eur J Pediatr. 2006;165(2):99-103.
43. Balion C, Grey V, Ismaila A, Blatz S, Seidlitz W. Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter. BMC Pediatr. 2006;6:28.
44. Tang Z, Louie RF, Payes M, Chang KC, Kost GJ. Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther. 2000;2(3):349-62.
45. Shafer MR. 1991 Federal Nursing Service Award recipient. The effect of increased atmospheric pressure on glucose reagent strip accuracy. Mil Med. 1992;157(4):162-5.
46. Price ME Jr, Hammett-Stabler C, Kemper GB, Davis MG, Piepmeier EH Jr. Evaluation of glucose monitoring devices in the hyperbaric chamber. Mil Med. 1995;160(3):143-6.
47. Edge CJ, Grieve AP, Gibbins N, O'Sullivan F, Bryson P. Effects of pressure on whole blood glucose measurements using the Bayer Glucometer 4 blood glucose meter. Undersea Hyperb Med. 1996;23(4):221-4. (Pubitemid 126499602)
48. Vote DA, Doar O, Moon RE, Toffaletti JG. Blood glucose meter performance under hyperbaric oxygen conditions. Clin Chim Acta. 2001;305(1-2):81-7. (Pubitemid 32203704)
49. Giordano BP, Thrash W, Hollenbaugh L, Dube WP, Hodges C, Swain A, Banion CR, Klingensmith GJ. Performance of seven blood glucose testing systems at high altitude. Diabetes Educ. 1989;15(5):444-8.
50. Fink KS, Christensen DB, Ellsworth A. Effect of high altitude on blood glucose meter performance. Diabetes Technol Ther. 2002;4(5):627-35. (Pubitemid 35283326)
51. Kilpatrick ES, Rumley AG, Smith EA. Variations in sample pH and pO2 affect ExacTech meter glucose measurements. Diabet Med. 1994;11(5):506-9. (Pubitemid 24210273)
52. King JM, Eigenmann CA, Colagiuri S. Effect of ambient temperature and humidity on performance of blood glucose meters. Diabet Med. 1995;12(4):337-40.
53. Nawawi H, Sazali BS, Kamaruzaman BH, Yazid TN, Jemain AA, Ismail F, Khalid BA. Effect of ambient temperature on analytical and clinical performance of a blood glucose monitoring system: Omnitest Sensor glucose meter. Ann Clin Biochem. 2001;38(Pt 6):676-83. (Pubitemid 33702274)
54. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Stow P. Circadian rhythm of blood glucose values in critically ill patients. Crit Care Med. 2007;35(2): 416-21. (Pubitemid 46148530)
55. U.S. Department of Health and Human Services; Food and Drug Administration. Medical device use-safety: incorporating human factors engineering into risk management. 2000 Jul 18 [cited 2009 Jun 14]. Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm094461.pdf.
56. Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. St. Louis, MO: Elsevier-Saunders; 2006. p. 868.
57. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Disease Control and Prevention. Current CLIA regulations. 2004 Jan 24 [cited 2009 Aug 11]. Available from: http://wwwn.cdc.gov/clia/regs/toc.aspx.
58. U.S. Department of Health and Human Services; Food and Drug Administration. Review criteria assessment of portable blood glucose monitoring in vitro diagnostic devices using glucose oxidase, dehydrogenase or hexokinase methodology [cited 2009 Jun 14]. Available from: http://www.fda.gov/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm094134.htm.
59. American Diabetes Association. Consensus statement on self-monitoring of blood glucose. Diabetes Care. 1996;19:S62-6.
60. Skeie S, Thue G, Nerhus K, Sandberg S. Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem. 2002;48(7):994-1003. (Pubitemid 34680893)
61. U.S. Department of Health and Human Services; Food and Drug Administration. Draft guidance for industry and FDA staff - total product life cycle for portable invasive blood glucose monitoring systems [cited 2009 Jun 14]. Available from: http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm079138.htm.
62. Flore KMJ, Delanghe JR. Analytical interferences in point-of-care testing glucometers by icodextran and its metabolites: an overview. Perit Dial Int. 2009;29(4):377-83.
63. Stork AD, Kemperman H, Erkelens DW, Veneman TF. Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia. Eur J Endocrinol. 2005;153(2):275-81. (Pubitemid 41167485)
64. Bland JM, Altman DG. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol. 2003;22(1):85-93. (Pubitemid 36886457)
65. Clarke WL. The original Clarke error grid analysis (EGA). Diabetes Technol Ther. 2005;7(5):776-9. (Pubitemid 41572081)
66. Winkelman JW, Wybenga DR, Tanasijevic MJ. The fiscal consequences of central vs distributed testing of glucose. Clin Chem. 1994;40(8):1628-30. (Pubitemid 24241163)
67. Khan AI, Vasquez Y, Gray J, Wians FH Jr, Kroll MH. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med. 2006;130(10):1527-32. (Pubitemid 44520721)
68. Wiener K. An assessment of the effect of haematocrit on the HemoCue blood glucose analyser. Ann Clin Biochem. 1993;30(Pt 1):90-3. (Pubitemid 23049427)
69. Finkielman JD, Oyen LJ, Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest. 2005;127(5):49-51.
70. Hoedemaekers CW, Klein Gunnewiek JM, Prinsen MA, Willems JL, Van der Hoeven JG. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med. 2008;36(11):3062-6.